Blue Faery's Benefactors Council Members
Our national membership giving program consists of corporations (and individuals) committed to giving a minimum annual gift of $5,000 per year for HCC-specific research, HCC educational programs, patient advocacy events, and/or corporate sponsorships.
View our 7th annual HCC Advocacy Partners Workshop (page is password-protected)
Blue Faery Benefactor
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Blue Faery Patron,
Founding Member
Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development, and commercialization of new medicines for difficult-to-treat cancers.
Blue Faery Supporter,
Founding Member
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases).
Blue Faery Supporter,
Founding Member
Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and life-threatening medical conditions.
Blue Faery Friend
Coherus Oncology is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of novel immunotherapies to treat cancer. For additional information, please visit coherus.com.
Blue Faery Friend
Eureka Therapeutics is a clinical-stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.